Become European Resident by Easy Investment

Having trouble seeing the below email? Click here to view it in your browser

Italian Golden Visa

Introduced in 2017 by the Italian government to encourage foreign direct investment, this visa offers an accessible path to residency in one of Europe's most captivating countries.

EUR 250K - Investment in an Italian innovative startup *Guaranteed buyback in 10 yrs + 3% annual returns. Register Your Interest Key Advantages Visa-free travel to Europe's Schengen Area Residence in a country with a rich culture, attractive industries, and major global cities including Milan, Rome and Venice Fast-track procedure with all documents issued in English. No need to take test in Italian language No minimum or permanent stay in Italy required Access to excellent medical care and education facilities Possibility to work or develop further businesses in Italy Citizenship may be available after 10 years of residence (under special conditions) Register Your Interest The application process typically takes 90-120 days Register Your Interest Special Tax Incentives Substitutive tax of EUR 200,000 covering any income sourced outside Italy to be paid yearly (up to 15 years). Availability to all individuals - including Italian citizens - transferring their tax residence to Italy if have been non Italian tax residents for income tax purposes for 9 out 10 years preceding their relocation to Italy Validity for 15 years. No reporting obligations in relation to foreign income and assets. No Italian inheritance and gift tax on foreign-situs assets Possibility of extension to family members by paying EUR 25,000 for each family member. Preventive ruling request to the Italian tax authorities to obtain official confirmation on the eligibility requirement Applicability of Double Taxation Treaties with 100+ countries. Tax residence certificate available. Register Your Interest © 2025. All Rights Reserved.

The Biggest IPOs Ever

Having trouble seeing the below email? Click here to view it in your browser

The Largest Healthcare IPO Ever

High-Growth Health & Pharma Opportunity

REVENUE GENERATING

Limited Allocation Remaining

Established product range already in market

Download Brochure >>>

REGISTER TO KNOW MORE

Company Overview Abundant Natural Pharmaceuticals (ANP) is an Australian-based pharmaceutical and nutraceutical platform focused on high-growth magnesium-based health products, including supplements, functional beverages, and therapeutic applications. The business is built on an existing commercial foundation, supported by its distributor and JV partner Abundant Natural Health, which already generates millions in revenue through established retail, pharmacy, and online channels. This provides ANP with an immediate route to market and reduced execution risk.

“Magnesium supports over 300 essential biochemical reactions in the body.” — National Institutes of Health New. Innovative. Ready to launch - be part of it. to market soon.

REGISTER TO KNOW MORE Revenue Generating Platform Products already selling across established retail, pharmacy, and online channels with daily-use products driving monthly repeat purchases and subscription-based income. Superior Product Quality & Pipeline Higher concentration of bioavailable magnesium vs typical market products. Scalable pipeline of supplements, liquids, beverages, and therapeutic applications.

EcoMag Integration Magnesium sourced via EcoMag (Karratha, Australia) from waste streams, delivering clean, traceable, environmentally responsible production. Backed by Abundant Natural Health with existing infrastructure and customer base.

Funding Round TOTAL RAISE (30% EQUITY) USD $1M SECURED USD $500K Minimum Entry:  AUD $30,000 The company is expected to scale through revenue and reinvestment, with no ongoing reliance on funding rounds.

REGISTER TO KNOW MORE

Investor returns Growth-led strategy initially Dividend distributions targeted from Year 2/3 onward Strong valuation upside as the platform scales Exit Strategy IPO  (Initial Public Offering) ASX listing as the company grows Strategic Acquisition (Buyout) Target for global pharmaceutical, nutraceutical, or wellness groups

Summary A rare opportunity combining: Established product range and proven market foundations Scalable, recurring revenue model Strong product differentiation ESG-aligned supply chain Limited capital requirement Clear exit strategies

REGISTER TO KNOW MORE

Access Full Investment Details

Download Brochure

In association with © Abundant Natural Pharmaceuticals Pty Limited. All rights reserved.

Invest in Movies

Having trouble seeing the below email? Click here to view it in your browser

Invest in the World’s First AI Animated Film

Earn 25% RETURN ON INVESTMENT EVERY YEAR FOR 15 YEARS

A fast-paced, funny and heartfelt adventure about friendship, invention and what it truly means to be alive. REGISTER FOR MORE INFORMATION Key Highlights ● ALREADY IN PRODUCTION ● Scheduled for release in early 2027 ● 15 Years royalty period ● AI-driven production significantly reduces cost, time, and risk ● Faster production timelines without compromising quality ● Multi-channel monetisation (theatrical, streaming, licensing, merchandise) ● Strong potential for high ROI ● First-mover advantage in AI-powered animation Key Creative Team Writer Michael Ferris Terminator: Rise of the machines The Simpsons Producers Diane Shorthouse John Adams Curfew Damaged Character Design Tony Bancroft Mulan The Lion King Environment Design Darren Fereday Doctor WHO Music Supervisor Maggie Rodford Wicked Ghostbusters: Frozen Empire Composer Ben Morales Frost Mission Impossible: Dead Reckoning GREAT PERKS & BENEFITS Attend set visits, meet the stars, private screenings, walk the red carpet, and see your name in the credits REGISTER FOR MORE INFORMATION Evolutionary Films Productions is an award-winning established production company that develop, produce and finance films and TV productions. Our projects have been successfully released on Amazon Prime, Netflix and VOD services nationwide. We are experienced in making high-quality production films with strict budget controls and a proven track record. Due to the controlled budgets, the film generates profit faster and the investors recoup their investment sooner. REGISTER FOR MORE INFORMATION